Integration of genomics, proteomics, and imaging for cardiac stem cell therapy

Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA, USA.
European journal of nuclear medicine and molecular imaging (Impact Factor: 5.38). 07/2007; 34 Suppl 1(S1):S20-6. DOI: 10.1007/s00259-007-0437-y
Source: PubMed


Cardiac stem cell therapy is beginning to mature as a valid treatment for heart disease. As more clinical trials utilizing stem cells emerge, it is imperative to establish the mechanisms by which stem cells confer benefit in cardiac diseases. In this paper, we review three methods - molecular cellular imaging, gene expression profiling, and proteomic analysis - that can be integrated to provide further insights into the role of this emerging therapy.

2 Reads
  • Source
    • "Reporter gene technology has a number of advantages over direct labeling of cells with imaging agents (Chun et al., 2007). Firstly, reporter gene imaging requires cellular viability. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The convergence of molecular and genetic disciplines with non-invasive imaging technologies has provided an oppor-tunity for earlier detection of disease processes which begin with molecular and cellular abnormalities. This emerging field, known as molecular imaging, is a relatively new dis-cipline that has been rapidly developed over the past decade. It endeavors to construct a visual representation, character-ization, and quantification of biological processes at the mo-lecular and cellular level within living organisms. One of the goals of molecular imaging is to translate our expanding knowledge of molecular biology and genomic sciences into good patient care. The practice of molecular imaging is still largely experimental, and only limited clinical success has been achieved. However, it is anticipated that molecular imaging will move increasingly out of the research laboratory and into the clinic over the next decade. Non-invasive in vivo molecular imaging makes use of nuclear, magnetic reso-nance, and in vivo optical imaging systems. Recently, an inter-est in Positron Emission Tomography (PET) has been re-vived, and along with optical imaging systems PET is assum-ing new, important roles in molecular genetic imaging studies. Current PET molecular imaging strategies mostly rely on the detection of probe accumulation directly related to the physi-ology or the level of reporter gene expression. PET imaging of both endogenous and exogenous gene expression can be achieved in animals using reporter constructs and radio-labeled probes. As increasing numbers of genetic markers become available for imaging targets, it is anticipated that a better understanding of genomics will contribute to the ad-vancement of the molecular genetic imaging field. In this re-port, the principles of non-invasive molecular genetic imag-ing, its applications and future directions are discussed.
    07/2007; 5:46-55.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several equations of mixing rule on permittivity have been proposed, but none of these equations is not perfect, because of too many different configurations exist in actual cases. Serial model and parallel model are two extremes of mixing manner. For the random mixture of fine particles, which does not have a remarkable aspect ratio, customarily the logarithmic mixing rule has been applied. But, the logarithmic mixing rule does not estimate the correct apparent permittivity in low or high mixing rate. The author proposed new equation for the mixing rule that gives better agreement with measured value for whole range of mixing rate compared to the logarithmic rule. In this paper, a desirable refinement on the equation in previous paper is made to adapt to the structural image of actual compound and then the equation has been expanded to the complex permittivity to apply the equation on the dissipative materials cases.
    Applications of Ferroelectrics, 2002. ISAF 2002. Proceedings of the 13th IEEE International Symposium on; 01/2002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Successful delivery of progenitor cells to the injury zone is a prerequisite for any effect of myocardial regeneration therapy. This key issue, however, has received far less attention than, for instance, a potential need for cell type selection or ex-vivo expansion, the optimal timing of cell application or multimodal functional evaluation after cellular transplantation. By combining myocardial perfusion scintigraphy, magnetic resonance imaging and 99Tc-HMPAO-labelled autologous bone marrow-derived CD34+ cells visualisation, we show in a 63-year-old man with a large anterior myocardial infarction that transcoronary applied cells (via the central lumen of an inflated over-the-wire balloon positioned in the stent implanted in primary PCI) graft preferentially to the infarct border zone. This is consistent with the idea that the area of myocardial 'irreversible' injury (i.e. the no-perfusion zone on perfusion scintigraphy or late enhancement zone on magnetic resonance) remains largely inaccessible to transcoronary-applied cells; thus other techniques need to be considered if the cell delivery is aimed at the zone of irreversible injury. The potency of such combined high-resolution visualisation provides grounds for comparing the efficacy of different methods of cell delivery after a recent myocardial infarction in man.
    Kardiologia polska 02/2008; 66(1):73-7. · 0.54 Impact Factor
Show more